# Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain

> **NCT03878082** · NA · COMPLETED · sponsor: **Mackay Memorial Hospital** · enrollment: 100 (actual)

## Conditions studied

- Uterine Pain

## Interventions

- **DRUG:** Propacetamol 1g
- **DRUG:** Propacetamol 2g
- **DRUG:** IVPCA

## Key facts

- **NCT ID:** NCT03878082
- **Lead sponsor:** Mackay Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-12
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03878082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03878082, "Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03878082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*